DE69325643T2 - Zusammensetzung zur raucherentwöhnung - Google Patents

Zusammensetzung zur raucherentwöhnung

Info

Publication number
DE69325643T2
DE69325643T2 DE69325643T DE69325643T DE69325643T2 DE 69325643 T2 DE69325643 T2 DE 69325643T2 DE 69325643 T DE69325643 T DE 69325643T DE 69325643 T DE69325643 T DE 69325643T DE 69325643 T2 DE69325643 T2 DE 69325643T2
Authority
DE
Germany
Prior art keywords
composition
pct
sec
pharmaceutically acceptable
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69325643T
Other languages
English (en)
Other versions
DE69325643D1 (de
Inventor
Richard Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McNeil AB
Original Assignee
Pharmacia and Upjohn AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn AB filed Critical Pharmacia and Upjohn AB
Application granted granted Critical
Publication of DE69325643D1 publication Critical patent/DE69325643D1/de
Publication of DE69325643T2 publication Critical patent/DE69325643T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Confectionery (AREA)
  • Cosmetics (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69325643T 1992-01-03 1993-01-04 Zusammensetzung zur raucherentwöhnung Expired - Lifetime DE69325643T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929200047A GB9200047D0 (en) 1992-01-03 1992-01-03 Nicotine-containing nasal spray
PCT/CA1993/000003 WO1993012764A1 (en) 1992-01-03 1993-01-04 Composition to help stop smoking

Publications (2)

Publication Number Publication Date
DE69325643D1 DE69325643D1 (de) 1999-08-19
DE69325643T2 true DE69325643T2 (de) 2000-02-10

Family

ID=10708064

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69325643T Expired - Lifetime DE69325643T2 (de) 1992-01-03 1993-01-04 Zusammensetzung zur raucherentwöhnung

Country Status (21)

Country Link
US (1) US5656255A (de)
EP (1) EP0619729B1 (de)
JP (1) JP3830158B2 (de)
KR (2) KR950700055A (de)
AT (1) ATE182070T1 (de)
AU (1) AU664415B2 (de)
CA (1) CA2127253C (de)
CZ (1) CZ294555B6 (de)
DE (1) DE69325643T2 (de)
DK (1) DK0619729T3 (de)
ES (1) ES2135460T3 (de)
FI (1) FI111049B (de)
GB (1) GB9200047D0 (de)
GR (1) GR3031075T3 (de)
HU (1) HUT73247A (de)
NO (1) NO308123B1 (de)
NZ (1) NZ246533A (de)
RU (1) RU2118897C1 (de)
SK (1) SK282336B6 (de)
UA (1) UA37201C2 (de)
WO (1) WO1993012764A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
AUPM835394A0 (en) * 1994-09-23 1994-10-13 King, Michael G. Dr. Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
JPH11507810A (ja) * 1995-06-05 1999-07-13 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Ｇタンパク質副甲状腺ホルモンレセプターｈｌｔｄｇ７４
CA2231968A1 (en) * 1998-03-11 1999-09-11 Smoke-Stop, A Partnership Consisting Of Art Slutsky Method of producing a nicotine medicament
GB9806937D0 (en) 1998-03-31 1998-05-27 Procter & Gamble A spray device
CA2359813C (en) 2000-10-24 2008-04-22 Richard L. Jones Nicotine mucosal spray
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
SE521512C2 (sv) * 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
DE60105820D1 (de) * 2001-10-22 2004-10-28 Pera Ivo E Zusammensetzung zur Reduzierung oder Entwöhnung von Nikotinabhängigkeit
SE0104388D0 (sv) * 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20030159702A1 (en) * 2002-01-21 2003-08-28 Lindell Katarina E.A. Formulation and use manufacture thereof
US20030171408A1 (en) * 2002-03-11 2003-09-11 Caplan Jay L. Therapeutic method of delivering a medicament to avoid irritating effects on membranes of user
US7767698B2 (en) 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
SE0201669D0 (sv) * 2002-06-03 2002-06-03 Pharmacia Ab New formulation and use thereof
US20040002520A1 (en) * 2002-07-01 2004-01-01 Soderlund Patrick L. Composition and method for cessation of Nicotine cravings
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
DE60313216T2 (de) * 2002-12-20 2008-01-03 Niconovum Ab Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose
CA2526432A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Self-contained heating unit and drug-supply unit employing same
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
WO2006031856A2 (en) 2004-09-13 2006-03-23 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US7766018B2 (en) * 2004-09-30 2010-08-03 Smoke-Break, Inc. Device and composition for reducing the incidence of tobacco smoking
US8322350B2 (en) 2004-12-30 2012-12-04 Philip Morris Usa Inc. Aerosol generator
US8323683B2 (en) 2005-05-18 2012-12-04 Mcneil-Ppc, Inc. Flavoring of drug-containing chewing gums
JP5694645B2 (ja) 2006-03-16 2015-04-01 ニコノヴァム エービーＮｉｃｏｎｏｖｕｍ Ａｂ 改善された嗅ぎたばこ組成物
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
EP1977746B8 (de) * 2007-04-02 2014-09-24 Parkinson's Institute Verfahren und Zusammensetzung zur Verringerung der Nebenwirkungen von therapeutischen Behandlungen
EP2218760B1 (de) * 2007-11-30 2015-09-02 Japan Tobacco Inc. Aerosolbildende lösung für einen aerosolaspirator
EP2233134A1 (de) 2009-03-27 2010-09-29 McNeil AB Mehrteilige intraorale Darreichungsform mit organoleptischen Eigenschaften
WO2011087393A1 (ru) * 2010-01-18 2011-07-21 Общество С Ограниченной Ответственностью "Вегавольт" Композиция растительного происхождения, предназначенная для вдыхания дыма, образующегося при ее сжигании
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
CA2841785A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
US10532046B2 (en) 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
WO2017149534A1 (en) * 2016-02-29 2017-09-08 Nicogen Ltd. Nicotine formulation and aerosols
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
SE541358C2 (en) 2017-05-30 2019-08-13 Enorama Pharma Ab Nicotine-containing chewing gum compositions
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
BR112020025604A2 (pt) 2018-06-15 2021-03-23 R.J. Reynolds Tobacco Company purificação de nicotina
CZ309558B6 (cs) * 2021-05-25 2023-04-12 Consumer Brands International s.r.o. Náplň nikotinového prostředku, zejména nikotinového sáčku a způsob jeho výroby

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2030862A (en) * 1978-04-10 1980-04-16 Smith A A composition for treating drug addiction such as smoking nicotine-containing products
DE3241437A1 (de) * 1982-11-10 1984-05-10 Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern
GB2133691B (en) * 1983-01-21 1986-05-21 Leo Ab Smoking substitutes for nasal administration
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
US4953572A (en) * 1985-04-25 1990-09-04 Rose Jed E Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4920989A (en) * 1985-04-25 1990-05-01 Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4715387A (en) * 1985-08-23 1987-12-29 The Regents Of The Univ. Of California Aerosol for use in the reduction of tobacco smoking
SE8601351D0 (sv) * 1986-03-24 1986-03-24 Nilsson Sven Erik Styrd administration av fysiologiskt aktiva emnen
GB8614805D0 (en) * 1986-06-18 1986-07-23 British American Tobacco Co Aerosol device

Also Published As

Publication number Publication date
US5656255A (en) 1997-08-12
NO942502L (no) 1994-09-02
NO308123B1 (no) 2000-07-31
CA2127253A1 (en) 1993-07-08
CZ294555B6 (cs) 2005-02-16
HUT73247A (en) 1996-07-29
ATE182070T1 (de) 1999-07-15
NO942502D0 (no) 1994-07-01
JPH07504164A (ja) 1995-05-11
WO1993012764A1 (en) 1993-07-08
FI943173A0 (fi) 1994-07-01
FI111049B (fi) 2003-05-30
FI943173A (fi) 1994-09-01
SK282336B6 (sk) 2002-01-07
CA2127253C (en) 1999-09-21
NZ246533A (en) 1996-04-26
EP0619729B1 (de) 1999-07-14
KR950700055A (ko) 1995-01-16
ES2135460T3 (es) 1999-11-01
GR3031075T3 (en) 1999-12-31
DK0619729T3 (da) 2000-04-17
JP3830158B2 (ja) 2006-10-04
RU94040387A (ru) 1996-10-20
UA37201C2 (uk) 2001-05-15
AU3340393A (en) 1993-07-28
KR100317426B1 (de) 2001-11-30
RU2118897C1 (ru) 1998-09-20
CZ160894A3 (en) 1995-09-13
AU664415B2 (en) 1995-11-16
HU9402003D0 (en) 1994-09-28
GB9200047D0 (en) 1992-02-26
EP0619729A1 (de) 1994-10-19
DE69325643D1 (de) 1999-08-19
SK79694A3 (en) 1995-06-07

Similar Documents

Publication Publication Date Title
DE69325643D1 (de) Zusammensetzung zur raucherentwöhnung
US5783207A (en) Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine
US5810018A (en) Method, composition and apparatus for reducing the incidence of cigarette smoking
HK12495A (en) Pharmaceutical formulations
FI955583A0 (fi) Nikotiinia sisältävä nasaalinen lääkkeenjakelukoostumus
FI944123A0 (fi) Farmaseuttiset inhalaatiokoostumukset
JPH072654A (ja) 吸入によるタウリン投与装置
IT1313585B1 (it) Uso di agonisti dei recettori gabab per la terapia di mantenimentodell'astinenza da nicotina in soggetti nicotino-dipendenti.
WO1996000071A1 (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a liquid nasal composition containing nicotine and caffeine or xanthine
PL297882A1 (en) Agent facilitating to lose the habit of cigarette smoking

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: PFIZER HEALTH AB, STOCKHOLM, SE

8327 Change in the person/name/address of the patent owner

Owner name: PFIZER CONSUMER HEALTHCARE HELTH AB, STOCKHOLM, SE

R071 Expiry of right

Ref document number: 619729

Country of ref document: EP